These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Salem L; Devlin A; Sullivan SD; Flum DR Surg Obes Relat Dis; 2008; 4(1):26-32. PubMed ID: 18069075 [TBL] [Abstract][Full Text] [Related]
12. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain. Tunis SL; Willis WD; Foos V Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377 [TBL] [Abstract][Full Text] [Related]
14. Assessing cost-effectiveness in obesity: laparoscopic adjustable gastric banding for severely obese adolescents. Ananthapavan J; Moodie M; Haby M; Carter R Surg Obes Relat Dis; 2010; 6(4):377-85. PubMed ID: 20655020 [TBL] [Abstract][Full Text] [Related]
15. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US. Tunis SL; Minshall ME Curr Med Res Opin; 2010 Jan; 26(1):151-62. PubMed ID: 19919376 [TBL] [Abstract][Full Text] [Related]
16. Revision of failed laparoscopic adjustable gastric banding to Roux-en-Y gastric bypass. van Wageningen B; Berends FJ; Van Ramshorst B; Janssen IF Obes Surg; 2006 Feb; 16(2):137-41. PubMed ID: 16469213 [TBL] [Abstract][Full Text] [Related]
17. A comparison of open and laparoscopic Roux-en-Y gastric bypass surgery for morbid and super obesity: a decision-analysis model. Siddiqui A; Livingston E; Huerta S Am J Surg; 2006 Nov; 192(5):e1-7. PubMed ID: 17071173 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding in the super-obese: a comparative study of 290 patients. Mognol P; Chosidow D; Marmuse JP Obes Surg; 2005 Jan; 15(1):76-81. PubMed ID: 15760503 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]